NCT03388372 2018-01-03Nimotuzumab Plus Radiotherapy With Concomitant and Adjuvant Temozolomide for Cerebral GlioblastomaBiotech Pharmaceutical Co., Ltd.Phase 2 Completed39 enrolled
NCT00600054 2011-07-06Phase 2 Study of Nimotuzumab in Pediatric Recurrent Diffuse Intrinsic Pontine GliomaYM BioSciencesPhase 2 Completed44 enrolled